Løken Senior Syndrome
Løken Senior Syndrome
National Organization for Rare Disorders, Inc.
It is possible that the main title of the report Løken Senior Syndrome is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
- Renal Dysplasia-Blindness, Hereditary
- Renal-Retinal Syndrome
- Senior-Loken Syndrome
- Juvenile Nephronophthisis with Leber Amaurosis
- Renal Dysplasia and Retinal Aplasia
- Renal-Retinal Dysplasia
Related Disorders List
Information on the following diseases can be found in the Related Disorders section of this report:
- Leber's Congenital Amaurosis
- Juvenile Nephronophthisis-Medullary Cystic Kidney Disease
- Polycystic Kidney Diseases
- Retinitis Pigmentosa
- Brachymorphism-Onychondysplasia-Dysphalangism Syndrome
- Nephronophthisis 1
- Rhyn's Syndrome
- Mainzer-Saldino Syndrome
Løken-Senior Syndrome is a rare disorder inherited as an autosomal recessive genetic trait. This disorder is characterized by progressive wasting of the filtering unit of the kidney (nephronophthisis), with or without medullary cystic renal disease, and progressive eye disease. Typically this disorder becomes apparent during the first year of life.
Løken-Senior Syndrome is a rare inherited disorder characterized by progressive kidney and eye problems.
The nephronophthisis with or without medullary cystic renal disease appears in the first year of life. The kidney problems are present at birth in some families, but develop very gradually and take a long time before symptoms become apparent in other families. Progressive failure of kidney function occurs as a result of degeneration or loss of function of the small collecting tubes (tubules) in the kidney. This can cause uremia and chronic interstitial nephritis.
Chronic interstitial nephritis is a kidney syndrome in which the spaces between the tissue of the kidney (interstitial) become inflamed and structural changes occur. Eventually the patient may have symptoms such as nausea, vomiting, weight loss, fatigue, anemia and ultimately kidney failure.
Uremia is a condition that is characterized by a gradual increase of urea and other by-products of protein breakdown in the blood, causing a severe toxic condition. Normally, these by-products of protein breakdown would be passed in the urine.
The progressive atrophy of the retina of the eye may be like Leber's Amaurosis with an absence of light gathering cells (cones and rods) of the retina at birth. A decrease in visual responsiveness at birth is the first sign of this disorder with roving eye movements (nystagmus) being apparent in the first two months of life.
In other cases of Løken-Senior Syndrome the progressive atrophy of the retina of the eye may take a course similar to Retinitis Pigmentosa. This condition typically becomes apparent later in life with the earliest symptom being difficulty seeing in dimly lit places (night blindness). This is slowly followed by tunnel vision. The rate of progression can vary.
Other symptoms have been noted in particular families such as diabetes insipidus, neurosensory hearing loss, muscular incoordination caused by disease of the cerebellum in the brain (cerebellar ataxia), abnormal formation of fibrous tissue in the liver (hepatic fibrosis) and skeletal abnormalities.
Løken-Senior Syndrome is inherited as an autosomal recessive trait. Recessive genetic disorders occur when an individual inherits the same abnormal gene for the same trait from each parent. If an individual receives one normal gene and one gene for the disease, the person will be a carrier for the disease, but usually will not show symptoms. The risk for two carrier parents to both pass the defective gene and, therefore, have an affected child is 25% with each pregnancy. The risk to have a child who is a carrier like the parents is 50% with each pregnancy. The chance for a child to receive normal genes from both parents and be genetically normal for that particular trait is 25%. The risk is the same for males and females.
The variability between families affected by Løken-Senior syndrome may be explained by different gene mutations in more than one gene (genetic heterogeneity). Several different gene abnormalities have been noted in individuals with Løken-Senior syndrome including a deletion of both copies of one of the genes for nephronophthisis (NPHP1), an abnormal gene near the NPHP3 locus on chromosome 3 and an abnormal gene overlapping the NPHP4 locus on chromosome 1.
Løken-Senior Syndrome is a very rare disorder affects males and females in equal numbers. There have been over one hundred and fifty cases of this disorder reported in the medical literature.
Symptoms of the following disorders can be similar to those of Løken-Senior Syndrome. Comparisons may be useful for a differential diagnosis:
Leber's Congenital Amaurosis is a retinal hereditary disorder of the eye. It is characterized by blindness at birth, roving eye movements, pupils that react poorly to light and dilate widely in the dark. However this disorder does not affect the kidney's. (For more information on this disorder, choose "Leber" as your search term in the Rare Disease Database.)
Juvenile Nephronophthisis-Medullary Cystic Disease is a diffuse kidney disease, either genetic or congenital in origin, which usually appears in children or young adults (juvenile nephronophthisis). It is characterized by a gradual increase of urea and other by-products of protein breakdown in the blood (uremia) due to progressive failure of kidney function. (For more information on this disorder, choose "Medullary Cystic Disease" as your search term in the Rare Disease Database.)
Polycystic Kidney Diseases are inherited disorders that are characterized by many cysts in both kidneys. This causes enlargement of the total kidney size, while reducing the functional kidney tissue by compression. (For more information on this disorder, choose "Polycystic Kidney Diseases" as your search term in the Rare Disease Database.)
Retinitis Pigmentosa is one of a group of inherited eye diseases causing degeneration of the retina. When the retina degenerates, the vision decreases from night blindness to tunnel vision, and vision may eventually be lost. Retinitis Pigmentosa may occur in association with other disorders such as deafness (Usher's Syndrome), central nervous system disorders, metabolic disorders and chromosomal abnormalities such as Turner Syndrome. (For more information on this disorder, choose "Retinitis Pigmentosa" as your search term in the Rare Disease Database.)
Brachymorphism-Onychodysplasia-Dysphalangism Syndrome is a rare disorder characterized by short stature, abnormal fingers and fingernails, facial abnormalities and mild mental retardation.
Nephronophthisis 1 is a rare disorder characterized by anemia, excessive urination (polyuria), excessive thirst (polydipsia) and toxic accumulation of the products of protein breakdown in the blood (uremia).
Rhyns Syndrome is an extremely rare disorder characterized by retinitis pigmentosa, nephronophthisis, low functioning pituitary gland (hypopituitarism), skeletal abnormalities, drooping eyelids and liver disease.
Mainzer-Saldino Syndrome is a rare disorder characterized by chronic kidney failure, skeletal abnormalities of the hands, retinitis pigmentosa and muscular incoordination (ataxia).
Patients with Medullary Cystic Disease need careful management of uremia when it occurs. Diet must be carefully monitored. An increase of calories in the diet should be coupled with a reduction in the total content of dietary protein. Sufficient carbohydrates and fats should be consumed to provide energy and prevent the body from metabolizing its own proteins.
Kidney failure may need to be managed with hemodialysis. Kidney transplantation is sometimes indicated.
When the retinal atrophy in Løken-Senior Syndrome resembles Retinitis Pigmentosa, the patient may benefit from various visual aids. The aids may be 1) optical aids, such as Corning and NOIR glasses, the Fresnel Prising telescopes, microscopes and night vision aids; 2)non-optical aids, such as the Wide Angle Mobility Light, paper guides, large print typewriters and adjustable stands; and 3) electronic aids such as Apollo Laser and Visualtek closed-circuit TV, reading machines and talking computers.
Genetic counseling may be of benefit for patients and their families.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Lewis RA. Løken-Senior Syndrome. In: The NORD Guide to Rare Disorders, Philadelphia: Lippincott, Williams, and Wilkins, 2003:692-3.
Buyse ML, Ed. Birth Defects Encyclopedia. Blackwell Scientific Publications, 1990. Pp.1463.
Schuman JS, et al. Senior-Løken syndrome (Familial Renal-Retinal Dystrophy) and Coat's disease. Am J Opthalmol. 1985:6:822-7.
Fillastre JP, et al. Senior-Løken syndrome (nephronophthisis and tapeto-retinal degeneration. Clin Nephrol. 1976;5(1):14-9.
Omran H, Sasmaz G, Haffner K, et al. Identification of a gene locus for Senior-Løken syndrome in the region of the nephronophthisis type 3 gene. J Am Soc Nephrol. 2002;13:75-79.
Scheuermann MJ, Otto E, Becker A, et al. Mapping of gene loci for nephronophthisis type 4 and Senior-Løken syndrome to chromosome 1p36. Am J Hum Genet. 2002;70:1240-1246.
Senior B, Friedman AI, Braudo JL. Juvenile familial nephropathy with tapetoretinal degeneration: a new oculorenal dystrophy. Am J Opthalmol. 1961;52:625-633.
Warady BA, Cibis G, Alon U, et al. Senior-Løken syndrome:revisited. Pediatrics. 1994;94:111-112.
FROM THE INTERNET
McKusick,VA, Ed. Online Mendelian Inheritance in Man (OMIM). The Johns Hopkins University. Entry Number; 266900: Last Edit Date; 12/26/2002.
Foundation Fighting Blindness
7168 Columbia Gateway Drive, Suite 100
Columbia, MD 21046
111 E 59th St
New York, NY 10022-1202
American Kidney Fund, Inc.
11921 Rockville Pike
Rockville, MD 20852
Retinitis Pigmentosa International
P.O. Box 900
Woodland Hills, CA 91365
National Association for Parents of Children with Visual Impairments (NAPVI)
P.O. Box 317
Watertown, MA 02272-0317
National Kidney Foundation
30 East 33rd Street
New York, NY 10016
Urology Care Foundation
1000 Corporate Blvd
Linthicum, MD 21090
NIH/National Eye Institute
31 Center Dr
Bethesda, MD 20892-2510
NIH/National Kidney and Urologic Diseases Information Clearinghouse
3 Information Way
Bethesda, MD 20892-3580
Blind Children's Center
4120 Marathon Street
Los Angeles, CA 90029-3584
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders, Inc.® (NORD). Cigna members can access the complete report by logging into myCigna.com. For non-Cigna members, a copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html.
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email email@example.com
Last Updated: 3/27/2008
Copyright 1993, 2003 National Organization for Rare Disorders, Inc.
Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.